Royal Philips has tapped biopharmaceutical company Merck to develop digital solutions for fertility treatment built on advanced informatics and artificial intelligence-enabled ultrasound diagnostics, Philips said Jan. 14.
These technology-driven solutions aim to better inform patients and clinicians about fertility treatment and maximize chances of conception, Philips said.
"The journey for aspiring parents is sometimes a difficult one, and by collaborating with Merck, a world leader in fertility treatment, we aim to develop integrated digital solutions that improve the patient experience and can ultimately have a positive impact on health outcomes," Jeroen Tas, Philips chief innovation and strategy officer, said in a press release.
More articles on health IT:
Parkland Health System launches virtual platform to train staff during pandemic
MUSC creates AI tool to predict patients' risks for COVID-19 complications
MedStar Health hospital transitions to new EHR